Stock Pattern Recognition Based on a Self-learning Algorithm: Returns up to 15.77% in 14 Days

Stock Pattern Recognition

This Healthcare Stocks Package is designed for investors and analysts who need predictions of the best shares within the Healthcare Sector. It includes 20 stocks with bullish and bearish signals and indicates the best healthcare stocks to buy and sell:

  • Top 10 HealthCare stocks for the long position
  • Top 10 HealthCare stocks for the short position

Package Name: HealthCare Stocks
Recommended Positions: Long
Forecast Length: 14 Days (04/12/2017 – 04/26/2017)
I Know First Average: 4.53%
Stock Pattern Recognition

In this 14 Days forecast for the HealthCare Stocks Package, there were many high performing trades and the algorithm correctly predicted 9 out 10 stocks. The top-performing prediction in this forecast was ALR, which registered a return of 15.77%. Other notable stocks were XOMA and ICAD with a return of 10.11% and 6.42%. The package had an overall average return of 4.53%, providing investors with a premium of 3.10% over the S&P 500’s return of 1.43% during the same period.

Alere Inc. (ALR) provides professional diagnostic products and services for infectious and cardiometabolic disease, and toxicology in the United States, Europe, and internationally. The company’s infectious disease products and services are used to detect various diseases, such as viral hepatitis; respiratory syncytial virus; influenza; streptococcus; pneumonia; tuberculosis; human immunodeficiency virus/acquired immunodeficiency syndrome; and gastrointestinal and vector-borne diseases, as well as syphilis and other sexually-transmitted diseases. It also offers indirect fluorescent antibodies; assays for 17 viral, bacterial, and autoimmune diseases; serology diagnostic products; and 40 enzyme-linked immunosorbent assays (ELISA), as well as a line of automated instrumentation for processing ELISA tests. The company’s cardiometabolic products and services include rapid diagnostic test systems for the diagnosis of critical care issues; point-of-care analyzers and test cassette systems for testing blood glucose, cholesterol, and related lipids; over-the-counter tests for cholesterol monitoring; blood analysis systems for blood gas, electrolyte, and metabolite testing; point-of-care diabetes products; and disposable and lateral flow rapid diagnostic tests for D-dimer and troponin. Its toxicology products and services include various device platforms for the detection of the illicit and prescription drugs of abuse; tests to detect alcohol; consumer drug testing products; and workplace drug and laboratory-based testing services. The company markets its professional diagnostic products through its sales force and distribution networks; and First Check consumer drug testing products through retail drug and food stores, drug wholesalers, and mass merchandisers. The company was formerly known as Inverness Medical Innovations, Inc. and changed its name to Alere Inc. (ALR) in July 2010. Alere Inc. (ALR) was founded in 1981 and is headquartered in Waltham, Massachusetts.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.